|
|
|
|
|
by vobios
4109 days ago
|
|
> Only about 10% enroll in clinical trials in the US, which only test one drug at a time. Clinical trials in the US test drug combinations and not just single drugs. > With 90% of the patients not enrolled in a clinical trial we wanted to design a commercial solution that could help patients today rather then relying on the standard of care. In other words, you are enrolling them in your own clinical trial without calling it such. Clinical trials are not perfect, but it's the best way we have to guarantee safety and efficacy. > The pathway for us is as a CLIA certified service similar to other personalized genomics companies in cancer like Foundation Medicine. Actually, it's very different. Foundation Medicine looks for known genetic variants and offers suggestions based on those. It is not offering novel or untested solutions. Their report is actually very poor if you are looking to make new discoveries. |
|